Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127134351 | 12713435 | 1 | I | 20160401 | 20160822 | 20160903 | 20160903 | EXP | GB-AUROBINDO-AUR-APL-2016-10880 | AUROBINDO | 24.00 | YR | M | Y | 59.87000 | KG | 20160903 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127134351 | 12713435 | 1 | PS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 MG, ONCE A DAY | 205 | MG | N | U | 78341 | 1 | MG | QD | |||
| 127134351 | 12713435 | 2 | C | BUDESONIDE. | BUDESONIDE | 1 | Respiratory (inhalation) | 100 ?G, UNK | U | 0 | 100 | UG | |||||||
| 127134351 | 12713435 | 3 | C | HYLO-FORTE | HYALURONATE SODIUM | 1 | Ophthalmic | U | 0 | ||||||||||
| 127134351 | 12713435 | 4 | C | LYMECYCLINE | LYMECYCLINE | 1 | Unknown | U | 0 | ||||||||||
| 127134351 | 12713435 | 5 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Unknown | U | 0 | ||||||||||
| 127134351 | 12713435 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 127134351 | 12713435 | 7 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127134351 | 12713435 | 1 | Alopecia |
| 127134351 | 12713435 | 2 | Product used for unknown indication |
| 127134351 | 12713435 | 3 | Product used for unknown indication |
| 127134351 | 12713435 | 4 | Product used for unknown indication |
| 127134351 | 12713435 | 5 | Product used for unknown indication |
| 127134351 | 12713435 | 6 | Product used for unknown indication |
| 127134351 | 12713435 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127134351 | 12713435 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127134351 | 12713435 | Depression | |
| 127134351 | 12713435 | Dizziness | |
| 127134351 | 12713435 | Erectile dysfunction | |
| 127134351 | 12713435 | Fatigue | |
| 127134351 | 12713435 | Feeling abnormal | |
| 127134351 | 12713435 | Headache | |
| 127134351 | 12713435 | Muscle twitching | |
| 127134351 | 12713435 | Muscular weakness | |
| 127134351 | 12713435 | Palpitations | |
| 127134351 | 12713435 | Penile size reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127134351 | 12713435 | 1 | 20150909 | 20160516 | 0 | |
| 127134351 | 12713435 | 2 | 20160311 | 0 | ||
| 127134351 | 12713435 | 3 | 20160607 | 0 | ||
| 127134351 | 12713435 | 4 | 20160614 | 20160811 | 0 | |
| 127134351 | 12713435 | 5 | 20160601 | 20160801 | 0 | |
| 127134351 | 12713435 | 6 | 20160101 | 0 | ||
| 127134351 | 12713435 | 7 | 20160614 | 20160801 | 0 |